Found: 5
Select item for more details and to access through your institution.
Crystal structure of ethyl 2-amino-4-(3-bromophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C<sub>21</sub>H<sub>16</sub>BrNO<sub>5</sub>.
- Published in:
- Zeitschrift für Kristallographie / New Crystal Structures, 2019, v. 234, n. 1, p. 95, doi. 10.1515/ncrs-2018-0201
- By:
- Publication type:
- Article
Crystal structure of methyl 4-(3-phenoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C<sub>26</sub>H<sub>27</sub>NO<sub>4</sub>.
- Published in:
- Zeitschrift für Kristallographie / New Crystal Structures, 2019, v. 234, n. 1, p. 53, doi. 10.1515/ncrs-2018-0135
- By:
- Publication type:
- Article
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.747075
- By:
- Publication type:
- Article
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.747075
- By:
- Publication type:
- Article
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.689076
- By:
- Publication type:
- Article